TrialFrontiers in immunology2021

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis.

Juan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.